FINWIRES · TerminalLIVE
FINWIRES

ASX Preview: Australian Shares Set to Rise; Bathurst Resources Says New Zealand High Court Dismisses Talley's Group Derivative Lawsuit Bid

By

Australian shares are poised to rise on Friday, mirroring gains on Wall Street, after US President Donald Trump said the US had cancelled planned strikes against Iran, and that the US and Iran could sign a peace agreement as soon as ​this weekend.

Overnight, the S&P 500 and the Dow Jones Industrial Average gained nearly 2%, while the the Nasdaq Composite rose 2.5%. Meanwhile, Brent oil futures fell below $89 per barrel.

In the macroeconomy, investors are eyeing the release of the labor account report at 11:30 am Sydney time.

In corporate news, Bathurst Resources (ASX:BRL) said a New Zealand court has dismissed Talley's Group's attempt to bring a derivative lawsuit involving Bathurst. Talley's first initiated the dispute in 2024 by filing a statement of claim against Bathurst, its directors, and related parties, alleging prejudiced shareholder conduct and misleading representations, and seeking damages.

Ebos Group (ASX:EBO, NZE:EBO) unit Pet Care Distributors' proposed deal to acquire Paringa Pet Foods is under a phase one review by the Australian Competition and Consumer Commission.

Australia's benchmark index shed 0.2% or 20.1 points to close at 8,633.20 on Thursday.

Related Articles

Asia

Kim Forest Enterprise Wins NT$110 Million Genome Sequencing Kit Supply Deal

Kim Forest Enterprise (TPE:6645) won a tender to supply whole genome sequencing assay kits to a national hospital in Taiwan under a contract worth NT$110 million, according to a Wednesday Taiwan Exchange filing.Shares slid about 2% in Thursday's late morning trade.The contract runs from June 10, 2026, to Dec. 31, 2028.Kim Forest said the deal is expected to expand its business operations and boost revenue.

$TPE:6645
Asia

Beijing Balance Medical Tech to Buy Back Up to 100 Million Yuan Worth of Shares

Beijing Balance Medical Technology (SHA:688198) plans to repurchase shares worth between 50 million yuan and 100 million yuan, according to a Shanghai bourse filing on Thursday.The company will buy back between 359,583 shares and 719,165 shares, which represents 0.26% to 0.52% of the company's total shares, within 12 months after the approval of the board of directors.The maximum repurchase price will be 139.05 yuan per share.The repurchased shares will be used for the company's employee stock ownership plan or equity incentives.The medical device manufacturer's shares rose 1% during the morning trade.

$SHA:688198
Asia

MediaTek's Sales Edge Up in April; Shares Drop 3%

MediaTek (TPE:2454) booked consolidated net sales of NT$47.4 billion in May, up 1.5% from NT$46.7 billion in April, according to a Wednesday Taiwan Exchange filing.Shares slid about 3% in Thursday's late morning trade.MediaTek did not provide further details in the filing.

$TPE:2454